08:00 Registration opens
09:00 Opening remarks
Morning session, chaired by Stephen Harding (University of Nottingham, UK)
09:15 Stability of Biopharmaceuticals: Past, present and future
Paul Varley (Medimmune, UK)
09:45 Antibody glycoforms and stability
Roy Jefferis (University of Birmingham, UK)
10:15 Speed Networking
11:00 Primary packaging for biopharmaceuticals: challenges & options
Horst Koller (Schott, Switzerland)
11:30 Exhibitors highlight
12:15 Lunch Break, Exhibition and Posters
Afternoon session, chaired by Ahmed Yassin (GSK, UK)
13:30 Introduction
13:45 Developability evaluation during early pre-formulation: the meeting point between research and development
Bernardo Perez-Ramirez (Genzyme, USA)
14:15 Evaluation of chemical stability during developability assessment of therapeutic antibodies
Daniel Heitmann (Novartis, Switzerland)
14:45 Coffee break, Exhibition and Posters
15:15 Discussion panel: Challenges of setting specifications for biopharmaceutical products
16:15 Glycoconjugate vaccine stability and formulation
Chris Jones (NIBSC, UK)
16:45 Concluding remarks
17:00 Conference ends